Global Coalition on Aging and Novim Join Forces to Create The Alliance To Beat COVID-19 (ABC): A Partnership to Build the Trust and Confidence to Defeat our Global Pandemic

New York, New York (December 18, 2020) – The Global Coalition on Aging (GCOA), the world’s leading business voice on aging, and science-based communications firm Novim today announced our innovative partnership – Alliance to Beat COVID (ABC) – to advance the goals of COVID-19 immunization for all. As two leaders in science and health strategy, Novim and GCOA are joining forces in our ABC campaign for an effective communication and education strategy that will help global society build trust in COVID-19 vaccines so that everyone around the globe will be confident and motivated to “get vaccinated.”

“There are five essential steps for the COVID-19 vaccine to work effectively: First, do no harm, ensure it is safe. Second, make sure it’s effective. Third, create sufficient scaled manufacturing to produce enough vaccine for all. Fourth, power a distribution system to get the vaccines to us. And fifth, get us to actually take it,” said Michael Hodin, CEO, Global Coalition on Aging.  “Stunningly, it is the fifth that will prove the greatest barrier as we see COVID-19 vaccine reluctance skyrocketing across our planet.”

Trust in the science of COVID-19 vaccine innovation follows a paradoxically well-known path where medicines generally, vaccines in particular and adult vaccines even more, are too often unused. According to a recent World Health Organization report, information, an enabling environment, social influence, and motivation influence vaccine acceptance. We live in a world in which, as the Annals of Internal Medicine reports, all medicine compliance is under 50%. For adult vaccines, it’s even worse, with only 37% of American adults vaccinated against the flu. The WHO reports that in the EU, just 60% of adults have received commonly recommended vaccinations, and in Australia, only half of the over-65 population has been vaccinated for flu and pneumococcal pneumonia. Even in super-aging Japan, where prevention and healthy aging are priorities for the population overall and rates of vaccine-preventable diseases like pneumococcal pneumonia are high, there persists remarkably low compliance. Compounding the reluctance further is the growing antivax and vaccine skeptics movements and the politicization of the COVID-19 vaccine.

“For our part,” said Michael Ditmore, Executive Director of Novim, “we will put our expertise in science, research, and analysis to evaluate and communicate on complex, complicated global scientific issues to the challenge of our moment – communicating the necessity and benefits of global immunization to Covid-19.”

For more information on the Alliance to Beat COVID, and how you can help, go to https://alliancetobeatcovid.org.

About Novim

Novim was founded in January of 2008 at the Kavli Institute for Theoretical Physics, at UC Santa Barbara, California with a mission to assemble teams of scientists to render complex issues comprehensible to non-scientists. These projects and studies are short duration efforts on a wide variety of subjects, delivering reports and web and mobile applications that help explain subjects ranging from nuclear power to pension reform to climate change.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.